This study is in progress, not accepting new patients
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Susan Perlman
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Susan Perlman
HS Clinical Professor, Neurology, Medicine. Authored (or co-authored) 172 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Biohaven Pharmaceuticals, Inc.
- ID
- NCT03701399
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 218 people participating
- Last Updated